11
Sep
2009
Tom Cech recently appeared on the CNBC pre-market morning program Squawk Box to discuss a variety of topics including the future of biomedical research, the Colorado Initiative in Molecular Biotechnology and the 1989 Nobel Laureate’s return to the University of Colorado where he will also be resuming teaching freshman chemistry. It is always fascinating to [...]
10
Jun
2008
Colorado life scientist’s and life science companies have recently been appearing left and right in the national spotlight, first in Popular Science then in Newsweek and now…Did you happen to catch 60 Minutes this past Sunday night? If not, the segment on Howard Hughes and how the Howard Hughes Medical Institute came to fruition featured [...]
02
Apr
2008
Thom Cech, Ph.D.: Sweet Home Colorado!
Posted in People
Thom Cech who has been serving as the President of the Howard Hughes Medical Institute (HHMI) since 2000 announced that he will be stepping down in the spring of 2009 and returning to Colorado. Dr. Cech plans to resume his position as an HHMI investigator at the University of Colorado, where he has been a [...]
27
Mar
2008
Congratulations to Assistant Professor Hang (Hubert) Yin, University of Colorado at Boulder Department of Chemistry and Biochemistry who has received the Kimmel Scholar Award from the Sidney Kimmel Foundation for Cancer Research. Dr. Yin is the first CU Boulder researcher to accept the prestigious award. The Sidney Kimmel Foundation for Cancer Research funds the Kimmel [...]
11
Mar
2008
What do you get when combing Colorado-based Nobel Laureate technology (Dr. John Hall, 2005-Physics) with Colorado-based All-Star management (Dr. Bill Freytag, Chair & CEO Aspreva Pharma, Chair & CEO Myogen)? Answer…alphsniffer…who announced the appointment of Dr. J. William Freytag as the new Chairman of the Board of Directors. Congratulations to Founder and CEO Misha Plam, [...]
06
Mar
2008
Norm Pace, Ph.D. of CU Molecular, Cell and Developmental Biology was honored by the CU Board of Regents with the distinction of Distinguished Professor. Dr. Pace can now add this title to his impressive list of accomplishments which include member of the National Academy of Sciences and the American Academy of Microbiology, as well as [...]
29
Feb
2008
Michael Bristow, M.D., Ph.D. Wins 2008 PhRMA Award
Posted in CO Pub Rel: Gilead, CO Pub Rel: GSK, CO Public: Myogen, People
Congratulations to Michael Bristow, M.D., Ph.D., the S. Gilbert Blount Professor of Medicine at University of Colorado, Head of Cardiology, Co-director of the University of Colorado Cardiovascular Institute, co-founder of Myogen (acquired by Gilead (NASDAQ: GILD), founder of ARCA Discovery and now add to that list winner of the Pharmaceutical Research and Manufacturers of America [...]
27
Feb
2008
All along the Front Range I can hear the sound of patents and articles-of-incorporation being filed, and new life science entities opening their doors. Larimer County is a concentrated region certainly a-buzz with such entrepreneurial activity. If you have not done so yet be certain to take a look at the Larimer Bioscience Cluster web [...]
25
Feb
2008
At FBBp we are afforded the opportunity to work with people of extraordinary caliber. One such individual is Sandeep Wadhwa, MD, MBA who has accepted a position within the Colorado Department of Health Care Policy and Financing where he will be functioning as the State’s Medicaid Program Director. In his new role Dr. Wadhwa will [...]
22
Feb
2008
Kythera Lands Joe Turner on Board
Posted in CO Pri Rel: Kythera Biopharma, CO Pub Rel: Merck, People
Joe Turner, former Chief Financial Officer at Myogen (now Gilead (NASDAQ: GILD)), has joined the privately held Los Angeles-based Kythera Biopharmaceuticals Board of Directors. Not only is Joe an incredibly talented executive and individual but most selfishly he too has had a profound impact upon my personal life and professional development, and for that I [...]
19
Feb
2008
Hiberna: In the Spotlight
Posted in CO Private: Hiberna, People
Very stealthy Boulder-based Hiberna Corporation has landed rather subtly on the radar, appearing in a Forbes article last week (read the article (here)). The piece is focused upon a variety of companies and technologies who are pursuing the potential clinical application of hibernation in order to slow metabolism thereby extending survival limits in traumas that [...]
04
Feb
2008
N30 Pharma is developing s-nitrosothiol therapies for critical unmet needs in respiratory diseases such as cystic fibrosis, asthma, and chronic obstructive pulmonary disease. A Phase I study of their lead molecule N30-201 used in healthy volunteers has been successfully completed. Safety and adverse events were characterized in addition to collecting pharmacokinetic and pharmacodynamic data of [...]
11
Jan
2008
A few weeks back I posted (here) about the news on Array BioPharma’s (NASDAQ: ARRY) outcome for ARRY-886 and the response Wall Street was having as well as AstraZeneca (NYSE: AZN), Array’s development partner, and Schering Plough (NYSE: SGP) and their competitive oncology product, reactions . My argument was that matching standard of care as [...]
Life Science Deal Flow PARTNERS
-
